“Proper review and interpretation of data” forms the core of monitoring care as continuous glucose monitoring changes daily patient support.
Continuous glucose monitoring allows pharmacists to educate people on how medications, physical activity, lifestyle, and other factors affect blood glucose levels, Joshua J. Neumiller explained in an interview with Pharmacy Times. Neumiller serves as senior vice president of medical affairs at the American Diabetes Association.
Optimal tracking requires careful evaluation, according to the ADA’s 7. Diabetes Technology: Standards of Care in Diabetes—2026, published on December 8, 2025, in Diabetes Care by the ADA Professional Practice Committee for Diabetes, Mandeep Bajaj, Rozalina G. McCoy, and 23 other authors. Bad numbers do not always mean a patient needs more medication. Technique problems often resolve quickly if a pharmacist watches a patient test, according to clinical associate Nicole Paolini Albanese.
One patient reported that testing hurt and frustrated her. When she demonstrated her technique at the pharmacy, Hudspeth found she was skipping the lancing device and jabbing the lancet directly into her finger. A simpler device solved the problem.
“Sometimes we assume a patient is just not adherent,” Hudspeth explained. “PreferredItem, I learned, was that we hadn’t given her the right tools.”
Device factors also distort readings. Expired or improperly stored test strips, abnormal hematocrit, and low oxygen tension at high altitudes can alter meter results. For continuous glucose monitors, patients must rely on a traditional meter while a sensor warms up. Certain medications, including specific doses of acetaminophen and vitamin C, can falsely raise sensor values.
Context protects patients from unnecessary medication changes, Nicole Paolini Albanese, PharmD, CDCES, BCACP, at the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, told Pharmacy Times. Without context, a prescriber might look at a log and say, “You had this one 200, and you’re always 100. We need to increase your medication,” when that may not be the case.
A patient who explains an outlier gives providers a more accurate picture. “This was an outlier because I was out the night before and I had a bottle of wine,” Albanese said.
Collaborative practice agreements allow pharmacists in some practices to assume increased responsibility, initiating, modifying, or discontinuing drug therapy under an agreement with a provider.
At the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, faculty such as clinical associate Nicole Paolini Albanese, PharmD, CDCES, BCACP, train pharmacists to interpret continuous glucose monitoring data within full clinical context, preventing unnecessary medication escalation from isolated outliers.
The school’s Department of Pharmacy Practice emphasizes that proper device technique and recognition of interfering factors — from medication effects to hematocrit levels — are essential competencies for pharmacists assuming expanded diabetes care roles.
“We know that important gaps exist in use of evidence-based therapies in diabetes, and pharmacists are well positioned to intervene and address gaps related to education, care coordination, access to therapies and technologies, and optimization of guideline-directed therapy,” Neumiller said.